Comparison of B-cell Depletion and Natalizumab for Treatment of Multiple Sclerosis: A Semi-supervised Causal Analysis (P8-1.008)
We compared BCD and NTZ in managing MS patient-reported disability progression using registry-linked electronic healthcare record (EHR) data.
Authors
- Dominic DiSanto (ORCID: https://orcid.org/0000-0002-8815-2169)
- Weijing Tang (ORCID: https://orcid.org/0000-0002-3543-9924)
- Zongqi Xia (ORCID: https://orcid.org/0000-0003-1500-2589)
- Tianxi Cai (ORCID: https://orcid.org/0000-0002-5379-2502)
- Wen Zhu
Institutions
- Harvard University (US)
- University of Pittsburgh (US)
- Carnegie Mellon University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209003
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00